Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma.
Paczkowska J, Tang M, Wright KT, Song L, Luu K, Shanmugam V, Welsh EL, Weirather JL, Besson N, Olszewski H, Porter BA, Pfaff KL, Redd RA, Cader FZ, Mandato E, Ouyang J, Calabretta E, Bai G, Lawton LN, Armand P, Rodig SJ, Liu XS, Shipp MA.
Paczkowska J, et al. Among authors: liu xs.
Nat Commun. 2024 Dec 30;15(1):10740. doi: 10.1038/s41467-024-54512-7.
Nat Commun. 2024.
PMID: 39737927